NCT06260371|CompletedDMC
National Observatory of Mycoplasma Infections in Children Under 18 Ages in France
ORIGAMI
Loading search results
ORIGAMI
Sponsor study identifier
observational
1,145
1 country
1
Study Start
September 1, 2023
Actual (reported)Primary Completion
February 1, 2025
Actual (reported)Study Completion
February 1, 2025
Actual (reported)This study was set up because of an unusual increase in the number of cases of mycoplasma infections in France between June and November 2023. Clinical data from children with mycoplasma infections will be collected to characterise this infection and facilitate hospital management.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
February 1, 2025
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 1, 2023
Actual (reported)February 7, 2024
Actual (reported)February 15, 2024
Actual (reported)February 1, 2025
Actual (reported)February 1, 2025
Actual (reported)Number of patients hospitalized for mycoplasma infections
Proportion of hospitalized children due to mycoplasma infections
1 year
medical characterisation of mycoplasma infections
Assessment of clinical, biological and microbiological characteristics of mycoplasma infections cases.
1 year
Identify risk factors of serious infection
1 year
Identify predictive signs of serious infection
1 year
Type of complications
1 year
Patients outcome
1 year
healthcare used for infected children
1 year
hospitalised children under 18 age, with Mycoplasma infection
ACTIV
Créteil, 94600, France
Chosidow A, Maakaroun-Vermesse Z, Ok V, Delecroix C, Le Roux P, Dommergues MA, de Larminat J, Jeziorski E, Ronjat P, Jaume L, Welfringer-Morin A, Bebear C, Gits-Muselli M, Viriot D, Roux CJ, Bechet S, Romain AS, Lorrot M, Cohen R, Levy C, Cohen JF; ORIGAMI Study Group. Post-COVID-19 resurgence of Mycoplasma pneumoniae infections in French children (ORIGAMI): a retrospective and prospective multicentre cohort study. Lancet Infect Dis. 2026 Apr;26(4):374-383. doi: 10.1016/S1473-3099(25)00598-5. Epub 2025 Nov 19.
nasopharyngeal, oropharyngeal, lung, pleural puncture, pleural fluid, skin swab, cerebrospinal fluid, biopsy, etc... taken during routine care may be stored at hospital and analysed later. These data could be explored during end-of-study analysis.
Corinne Levy
Association Clinique Thérapeutique Infantile du val de Marne
Anais Chosidow
Hôpital Intercommunal de Villeneuve-Saint-Georges
Emilie Pauquet
Hôpital des Enfants, CHU de Bordeaux
1,145 participants (actual enrollment reported by the registry).
First Submitted
February 7, 2024
First Posted
February 15, 2024
Study Start
September 1, 2023
Actual (reported)The Impact of Starbright World on Children Being Treated at the NIH
Contact the study team to confirm eligibility.
Primary Completion
February 1, 2025
Actual (reported)Study Completion
February 1, 2025
Actual (reported)Last Updated
March 19, 2026
Record last verified: 2026-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: